It has been proposed that the renin-angiotensin-aldosterone system and the prostaglandin system interact in a complicated manner to regulate systemic blood pressure and water electrolyte homeostasis. It is well known that release of renin is stimulated by furosemide administration as well as by low sodium diets (Davis and Freeman 1976 
PATIENTS AND METHODS
Eleven patients with essential hypertension who had normal renal function were studied in Tohoku University Hospital.
They consisted of 5 men and 6 women, aged from 22 to 59 with an average of 37.
All medications were stopped for at least 2 weeks prior to the study. Subjects were given 200 mEq/day of sodium for 7 days to achieve equilibration with this diet. This period was used as a control. Then, diets containing 100 mEq/day of sodium and furosemide, 40 mg orally every 12 hr, were given for 6 days, and indomethacin, 50 mg orally every 8 hr, was added for 3 days in the latter half of this period.
Sampling of peripheral vein blood for plasma renin activity and plasma aldosterone concentration was done from fasting subjects the next morning of the last day of each period. Collection of 24 hr urine for urinary sodium excretion and urinary prostaglandin E excretion was done on the last day of each period. Blood pressures were monitored with a sphygnomanometer immediately before the sampling of peripheral vein blood .
Plasma renin activity was measured by our modified method of Haber et al . using radioimmunoassay of angiotensin I (Abe et al. 1972 ). This procedure consisted of 6 hr incubation of 1 ml of plasma, at pH 5.5, with disodium ethylene-tetraacetic acid and diisopropyl fluorophosphate, and the radioimmunoassay of angiotensin I generated during the incubation.
Plasma aldosterone concentration was also determined by radioim munoassay with commercial kits after extracted with ethyl acetate . Urinary prostaglandin E excretion was determined as described previously (Abe et al . 1977; Yasujima et al. 1978) .
RESULTS
The effects of indomethacin on plasma renin activity, plasma aldosterone concentration , urinary sodium excretion and urinary prostaglandin E excretion during sodium depletion In our previous report, we showed that the injection of furosemide as a bolus induced increases in urine volume and urinary sodium excretion together with an increase in urinary prostaglandin E excretion in normal subjects and essential hypertensives (Abe et al. 1977) .
It had been known that furosemide might modify the catabolism of the prostaglandin system through the effects on 15-hydroxy dehydrogenase and 9-ketoreductase (Hansen 1976; Stone and Hart 1976) . Weber et al. (1976) also reported that furosemide induced an increase in arachidonic acid, known as a precursor of prostaglandin.
Therefore, we proposed that diuretic and natriuretic effects of furosemide might be mediated in part by renal prostaglandin. On the other hand, we observed a reduction in the excretion of urinary prostaglandin E in the face of an increase in renin-angiotensin-aldosterone system after sodium depletion (Yasujima et al. 1978) . The failure of the increase in the excretion of urinary prostaglandin E during furosemide administration and low sodium diets in this experiment may be explained by the opposing effects of sodium and furosemide.
Though urinary prostaglandin E excretion did not exhibit the significant change after furosemide administration and low sodium diets, the present result might not necessarily rule out the correlation between renin-angiotensin-aldosterone and renal prostaglandin systems, because the effects of furosemide administration on urinary prostaglandin E excretion may be masked with low sodium diets, and because indomethacin, a prostaglandin synthetase inhibitor, induced a decrease in plasma renin activity and plasma aldosterone concentration. After the administra tion of indomethacin, the relationship between the changes in plasma aldosterone concentration and in urinary prostaglandin E excretion was lost, while there was a close correlation between the changes in plasma renin activity and in urinary prostaglandin E excretion. Indomethacin did not effect on urinary sodium excretion. The present data suggest that renal prostaglandin E plays a role in the regulation of renin release during furosemide administration and low sodium diets and that the decrease in plasma aldosterone concentration after the indomethacin treatment is secondary to the decrease in plasma renin activity.
The depressor effects of sodium depletion with furosemide administration and low sodium diets cannot be explained only by acute volume depletion. Though a decrease in body weight of about 1.5 kg was observed in all subjects, the addition of indomethacin during furosemide administration and low sodium diets induced an elevation of blood pressure without any changes in urinary sodium excretion or body weight. It is well known that prostaglandin in vascular wall may modulate the effects of pressor substances, angiotensin II and noradrenaline (Vane and McGiff 1975) . The pressor effect of indomethacin may be due to the inhibition of prostaglandin synthesis in the vascular wall. To understand the hypotensive effects of furosemide administration and low sodium diets, it is necessary to know the role of prostaglandin in the vascular wall.
The present results show that renal prostaglandin E may play a role in the secretion and release of renin. Furthermore, the present experience suggests that the use of indomethacin, as an anti-inflammatory drug, may impair the hypotensive effects of furosemide and other diuretics.
